KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash from Operations: 2017-2025

Historic Cash from Operations for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to -$47.6 million.

  • Twist Bioscience's Cash from Operations rose 22.89% to -$11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.6 million, marking a year-over-year increase of 25.69%. This contributed to the annual value of -$47.6 million for FY2025, which is 25.69% up from last year.
  • Latest data reveals that Twist Bioscience reported Cash from Operations of -$47.6 million as of FY2025, which was up 25.69% from -$64.1 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Cash from Operations ranged from a high of -$47.6 million in FY2025 and a low of -$142.5 million during FY2023.
  • In the last 3 years, Twist Bioscience's Cash from Operations had a median value of -$64.1 million in 2024 and averaged -$84.7 million.
  • As far as peak fluctuations go, Twist Bioscience's Cash from Operations fell by 14.54% in 2023, and later soared by 55.01% in 2024.
  • Over the past 5 years, Twist Bioscience's Cash from Operations (Yearly) stood at -$112.2 million in 2021, then fell by 10.82% to -$124.4 million in 2022, then fell by 14.54% to -$142.5 million in 2023, then spiked by 55.01% to -$64.1 million in 2024, then increased by 25.69% to -$47.6 million in 2025.